¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"renal dwarfism"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • renal calyx
    ÄáÆÏÀÜ, ½Å¹è
  • renal cancer
    ÄáÆÏ¾Ï, ½ÅÀå¾Ï
  • renal cast
    ÄáÆÏ¿øÁÖ
  • renal cell carcinoma
    ÄáÆÏ¼¼Æ÷¾ÏÁ¾, ½ÅÀå¼¼Æ÷¾ÏÁ¾
  • renal column
    ÄáÆÏ±âµÕ, ½ÅÀå¿øÁÖ
  • renal cortex
    ÄáÆÏ°ÑÁú, ½ÅÀåÇÇÁú
  • renal cortical necrosis
    ÄáÆÏ°ÑÁú±«»ç, ½ÅÀåÇÇÁú±«»ç
  • renal crisis
    ÄáÆÏÀ§±â
  • renal cyst
    1. ÄáÆÏ³¶, ½ÅÀå³¶ 2. ÄáÆÏ³¶Á¾, ½ÅÀå³¶Á¾
  • renal disease
    ÄáÆÏº´, ½ÅÀ庴
  • renal disorder
    ÄáÆÏÀå¾Ö, ½ÅÀåÀå¾Ö
  • renal failure
    ÄáÆÏ±â´É»ó½Ç, ½ÅºÎÀü
  • renal function test
    ÄáÆÏ±â´É°Ë»ç, ½ÅÀå±â´É°Ë»ç
  • renal glycosuria
    ÄáÆÏ´ç´¢, ½ÅÀ强´ç´¢
  • renal hematuria
    ÄáÆÏÇ÷´¢, ½ÅÀ强Ç÷´¢
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • effective renal plasma flow
    À¯È¿ÄáÆÏÇ÷Àå·ù·®
  • renal arteriovenous fistula
    ÄáÆÏµ¿Á¤¸Æ»û±æ, ½ÅÀ嵿Á¤¸Æ·ç
  • renal glycosuria
    ÄáÆÏ´ç´¢
  • renal ablation glomerulosclerosis
    ÄáÆÏÀýÁ¦Å丮±»À½Áõ, ½ÅÀýÁ¦»ç±¸Ã¼°æÈ­Áõ
  • renal hematuria
    ÄáÆÏÇ÷´¢
  • renal hemophilia
    ÄáÆÏÇ÷¿ìº´, ½ÅÀåÇ÷¿ìº´
  • renal hypertension
    ÄáÆÏ°íÇ÷¾Ð
  • renal impression
    ÄáÆÏÀÚ±¹, ½ÅÀå¾ÐÈç
  • renal solute load
    ÄáÆÏ¿ëÁúºÎÇÏ, ½ÅÀå¿ëÁúºÎÇÏ
  • radioisotope renal clearance method
    ¹æ»ç¼ºµ¿À§¿ø¼ÒÄáÆÏÁ¦°ÅÀ²ÃøÁ¤¹ý
  • necrotizing renal papillitis
    ±«»çÄáÆÏÀ¯µÎ¿°
  • renal nanism
    ÄáÆÏ³­ÀåÀÌÁõ
  • renal cortical necrosis
    ÄáÆÏ°ÑÁú±«»ç
  • renal papillary necrosis
    ÄáÆÏÀ¯µÎ±«»ç
  • renal tissue nephroblastoma
    ÄáÆÏÁ¶Á÷ÄáÆÏ¸ð¼¼Æ÷Á¾, ½ÅÀåÁ¶Á÷½ÅÀå¸ð¼¼Æ÷Á¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • renal ablation glomerulosclerosis
    ½ÅÀýÁ¦»ç±¸Ã¼°æÈ­Áõ(ãìï·ð¶ÞêϹô÷Ìãûùñø)
  • renal abscess
    ½ÅÇÇÁú³ó¾ç
  • renal abscess
    ½Å³ó¾ç(ãìÒÛåË)
  • renal acidosis
    ½Å¼º»êÁõ.
  • renal acidosis
    ½Å¼º»êÁõ(ãìàõß«ñø)
  • renal adenocarcinoma
    ½Å ¼±¾Ï
  • renal adenoma
    ½Å¼±Á¾
  • renal agenesis
    ½Å¹«¹ßÀ°Áõ(ãìÙíÛ¡ëÀñø)
  • renal albuminuria
    ½Å¼º´Ü¹é´¢(ãìàõÓ±ÛÜèñ).
  • renal albuminuria
    ½Å¼º´Ü¹é´¢(ãìàõÓ±ÛÜèñ)
  • renal amino aciduria
    ½Å¼º ¾Æ¹Ì³ë»ê´¢
  • renal aminoaciduria
    ½Å¼º¾Æ¹Ì³ë»ê´¢(ãìàõ¡­ß«èñ).
  • renal aminoaciduria
    ½Å¼º¾Æ¹Ì³ë»ê´¢(¡­ß«èñ)
  • renal anasarca
    ½Å¼ºÀü½Å¼öÁ¾(ãìàõîïãóâ©ðþ).
  • renal anasarca
    ½Å¼ºÀü½Å¼öÁ¾(¡­îïãóâ©ðþ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • central renal echo complex
    ½ÅÁ᫐ (ãìñéãý) ¿¡ÄÚ º¹ÇÕü (ÜÜùêô÷), ½ÅÁ᫐ (ãìñé
  • central renal echo complex
    ½ÅÁ᫐ ¿¡ÄÚ º¹ÇÕü
  • chronic renal failure
    ¸¸¼º½ÅºÎÀü(¡­ãìÝÕîû).
  • chronic renal failure
    ¸¸¼º½ÅºÎÀü(¡­ãìÝÕîû).
  • chronic renal failure, CRF
    ¸¸¼º ½ÅºÎÀüÁõ
  • collecting renal tubule
    ÁýÇÕ¼¼°ü
  • crossed renal cctopia
    ±³Â÷(¼º) ½ÅÀ̼Ò(Áõ)
  • crossed renal ectopy
    ±³Â÷(¼º) ½ÅÀ̼Ò(Áõ)(¡­ãìì¶á¶ñø).
  • cyst,renal
    ½Å(ãì)
  • cystic renal dysplasia
    ³¶¼º ½ÅÀÌÇü¼º(Áõ)
  • cystic renal dysplasia
    ³¶¼º ½Å ÀÌÇü¼ºÁõ(¡­ãìì¶û¡à÷ñø)
  • cystic renal medullar
    ³¶¼º ½Å ¼öÁú(¡­ãìâÐòõ)
  • effective renal blood flow
    À¯È¿½ÅÇ÷·ù(·®)
  • effective renal blood flow =ERBF
    À¯È¿½ÅÇ÷·ù·®(êóüùãìúì×µÕá).
  • effective renal blood flow =ERBF
    À¯È¿½ÅÇ÷·ù·®.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Renal lobe
    ÄáÆÏ¿±
    [¿¾ ¿ë¾î] ½ÅÀå¼Ò¿±
  • Renal lobes
    ÄáÆÏ¿±
    [¿¾ ¿ë¾î] ½Å¿±
  • Renal papilla
    ÄáÆÏÀ¯µÎ
    [¿¾ ¿ë¾î] ½ÅÀ¯µÎ
  • Renal papillae
    ÄáÆÏÀ¯µÎ
    [¿¾ ¿ë¾î] ½ÅÀ¯µÎ
  • Renal impression
    ÄáÆÏÀÚ±¹
    [¿¾ ¿ë¾î] ½Å¾ÐÈç
  • Renal veins
    ÄáÆÏÁ¤¸Æ
    [¿¾ ¿ë¾î] ½ÅÁ¤¸Æ
  • Renal tissue (Nephroblastoma)
    ÄáÆÏÁ¶Á÷ (ÄáÆÏ¸ð¼¼Æ÷Á¾)
    [¿¾ ¿ë¾î] ½ÅÁ¶Á÷
  • Renal pyramid
    ÄáÆÏÇǶó¹Ô
    [¿¾ ¿ë¾î] ½ÅÃßü
  • Renal pyramids
    ÄáÆÏÇǶó¹Ô
    [¿¾ ¿ë¾î] ½ÅÃßü
  • Renal capsule
    ÄáÆÏÇǸ·
    [¿¾ ¿ë¾î] ½ÅÇǸ·
  • Renal blood vessel
    ÄáÆÏÇ÷°ü
    [¿¾ ¿ë¾î] ½ÅÀåÇ÷°ü
  • Major renal calices
    Å«(ÄáÆÏ)¼úÀÜ
    [¿¾ ¿ë¾î] ´ë½Å¹è
  • Base of renal pyramid
    ÇǶó¹Ô¹Ù´Ú
    [¿¾ ¿ë¾î] ÃßüÀú
  • Arcuate renal tubule
    Ȱ²Ã¼¼°ü
    [¿¾ ¿ë¾î] ±Ã»ó¿ä¼¼°ü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ERPF Effective Renal Plasma Flow; À¯È¿½ÅÇ÷·ù·®
ESRD End Stage Renal Disease
FENa, FeNa Fractional Excretion of Sodium
  ; VolumeÀÇ °³³äÀ» Á¦°ÅÇÏ¿© Á» ´õ Á¤È®ÇÑ ½ÅÀåÀÇ ³óÃà ´É·ÂÀ» Æò°¡,
 &n...
HFRS Hemorrhagic Fever with Renal Syndrome [HP 849-50]
  = Korean Hemorrhagic Fever
&nbs...
MURCS Associations MUllerian duct aplasia, Renal aplasia, Cervico-thoracic vertebral(Somite) dysplasia Associations
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CRG Compensatory renal growth
CRRT Continuous Renal Replacement Therapy
CRRTs Continuous renal replacement therapies
DRTA Distal renal tubular acidosis
ERPF Effective Renal Plasma Flow
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • renal calcinosis
    ½Å ¼®È¸È­Áõ
    µ¿ÀǾî=ne
  • renal calculi
    ½Å °á¼®
  • renal calyces
    ½Å¹è
  • renal cancer
    ½Å ¾Ï
  • renal capsular flap
    ½Å ÇǸ·Æí
  • renal capsulotomy
    ½ÅÇǸ· Àý°³, ½ÅÇǸ· Àý°³¼ú
  • renal carcinosarcoma
    ½Å¾Ï À°Á¾
  • renal causes of hyperkalemia
    ½Å¼º °íÄ®·ýÇ÷Áõ
  • renal cell carcinoma
    ½Å ¼¼Æ÷ ¾ÏÁ¾
  • renal circulation
    ½ÅÀå ¼øÈ¯, ½Å¼øÈ¯
  • renal clearance test
    ½Å Ŭ¸®¾î·±½º Å×½ºÆ®
  • renal colicky pain
    ½Å »êÅë
  • renal column
    ½ÅÀå ±âµÕ, ½ÅÁÖ
  • renal contusion
    ½Å Á»ó
  • renal cortical adenoma
    ½Å ÇÇÁú ¼±Á¾
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
Laron type dwarfism Dwarfism associated with an absent or very low levels of somatomedin C (insulin-like growth factor I) or abnormalities in receptor activity.
(05 Mar 2000)
Frohlich's dwarfism Dwarfism with Frohlich's syndrome.
(05 Mar 2000)
lethal dwarfism Dwarfism leading to intrauterine or neonatal death.
(05 Mar 2000)
Lorain-Levi dwarfism Short stature due to underpreformance of the pituitary gland (specifically of the anterior pituitary).
(12 Dec 1998)
acute renal failure <nephrology> A sudden decline in renal function may be triggered by a number of acute disease processes.
Examples include sepsis (infection), shock, trauma, kidney stones, kidney infection, drug toxicity (aspirin or lithium), poisons or toxins (drug abuse) or after injection with an iodinated contrast dye (adverse effect).
Chronic renal failure represents a slow decline in kidney function over time. Chronic renal failure may be caused by a number of disorders which include long-standing hypertension, diabetes, congestive heart failure, lupus or sickle cell anaemia. Both forms of renal failure result in a life-threatening metabolic derangement.
(27 Sep 1997)
aminoaciduria, renal Impairment of renal tubular transport of amino acids.
(12 Dec 1998)
back-pressure renal atrophy <radiology> Caliectasis without obstruction, due to repeated episodes of obstruction, gradual loss of renal pyramids
(12 Dec 1998)
base of renal pyramid The outer broad part of a renal pyramid that lies next to the cortex.
Synonym: basis pyramidis renis.
(05 Mar 2000)
branchio-oto-renal syndrome <syndrome> An autosomal dominant disorder manifested by various combinations of preauricular pits, branchial fistulae or cysts, lacrimal duct stenosis, hearing loss, structural defects of the outer, middle, or inner ear, and renal dysplasia. Associated defects include asthenic habitus, long narrow facies, constricted palate, deep overbite, and myopia. Hearing loss may be due to mondini type cochlear defect and stapes fixation.
(12 Dec 1998)
capsular branches of renal artery <anatomy, artery> Branches arising from the renal artery outside of the kidney that are distributed to the renal capsule.
Synonym: rami capsulares arteriae renalis.
(05 Mar 2000)
captopril renal scan <radiology> In a kidney with a lesion in the afferent arteriole (e.g. Atherosclerotic plaque), reflex constriction of the efferent arteriole occurs through angiotensin system thus maintaining renal perfusion. ACE inhibition prevents constriction of efferent arteriole. Therefore, perfusion is decreased to a kidney with afferent lesions and the renal scan to looks WORSE. Bottom line: renal scans appear WORSE with captopril administration if there is a lesion in the afferent arteriole. See: renal artery stenosis
(12 Dec 1998)
carcinoma, renal cell Carcinoma of the renal parenchyma usually occurring in middle age or later and composed of tubular cells in varying arrangements. It was first described in 1826. Possible causal factors are environmental, hormonal, cellular, and genetic. Smoking is a definite risk factor and obesity is associated with increased risk. Renal cell carcinoma accounts for approximately 3% of adult cancer; the male-female ratio is 2:1. It is more common among urban residents than rural.
(12 Dec 1998)
renal <anatomy> Pertaining to the kidney, nephric.
(18 Nov 1997)
renal adenocarcinoma <radiology> Hypernephroma, renal cell carcinoma, arises from proximal collecting tubule, 10% bilateral adenocarcinoma types: papillary, alveolar, onchocytoma vascularity, 85% hypervascular (require pre-op embolization), 10% hypovascular (usually papillary type), 5% avascular associated with: tuberous sclerosis, von Hippel-Lindau syndrome see also: staging
(12 Dec 1998)
renal adenocarcinoma: staging <radiology> Typical presentation: Haematuria . . . . . 70% Fever . . . . . . . 16% Pain . . . . . . . . 50% Polycythemia . . . . 3% Palpable mass . . . 20% Anatomic staging (TNM): T1 Small tumour, kidney not enlarged T2 Large tumour, contained within renal capsule T3 Extension into perinephric fat or renal vein T4 Invasion of adjacent organs
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á